You are here
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
SBC: AGAVE BIOSYSTEMS INC. Topic: N/A
The preponderance of biosensors under development today rely on labeling reagents such as fluorescent, radioisotopic or enzymatic tags. As a result, the added complexity of these reagents and their incorporation into the detection system has resulted in designs that are difficult to implement or that require significant sample preparation steps before introduction into the detection instrument. ...SBIR Phase I 1998 Department of DefenseOffice for Chemical and Biological Defense
SBC: Invitro Diagnostics, Inc. Topic: N/A
Current geopolitical strategies require effective warfare countermeasures to protect U.S. forces against biological and chemical threats. Today's molecular biology and immunological detection technologies cannot be used to produce automated biodetectors useable in the battlefield. New, improved detection technologies are needed to minimize the impact of chemical and biological weapons on Army per ...SBIR Phase I 1998 Department of DefenseOffice for Chemical and Biological Defense
SBC: Phoebus Optoelectronics LLC Topic: CBD11102
We will continue developing a plasmonic metamaterial with strong absorption within a narrow band that is dynamically tunable over the 8-10 micron range. A metamaterial consisting of one or more bi-layers of thin metal and dielectric films will trap, concentrate and absorb a narrow frequency band while strongly reflecting out-of-band light. Tuning the frequency of the absorption band may be achiev ...SBIR Phase II 2013 Department of DefenseOffice for Chemical and Biological Defense